Study of Immune Globulin Intravenous (Human) GC5107 in Pediatric Subjects With Primary Humoral Immunodeficiency
Clinical trial NCT04565015 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04565015
- Sponsor
- GC Biopharma Corp
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-21
- Primary completion
- 2026-05-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.